HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adenovirus infections in adult recipients of blood and marrow transplants.

Abstract
Adenoviruses are increasingly recognized pathogens that affect blood and marrow transplant (BMT) recipients. Experiences with 2889 adult BMT recipients were reviewed to study the incidence, clinical spectrum, risk factors for dissemination, response to therapy, and outcome of adenovirus infections. Eight-five patients (3%) were diagnosed by means of culture (n=85) or culture and histopathological examination (n=6). Nine patients had asymptomatic viruria, and 76 had symptomatic infections, which included upper respiratory tract infection (n=20), enteritis (n=18), hemorrhagic cystitis (n=10), pneumonia (n=15), and disseminated disease (n=13). The overall mortality rate was 26%. A higher mortality rate was observed among patients with pneumonia (73%) and disseminated disease (61%). Risk factors for dissemination included receipt of an allogeneic transplant, presence of graft-versus-host disease (GVHD), and receipt of concurrent immunosuppressive therapy. Intravenous ribavirin was not associated with an appreciable benefit among 12 patients who received this treatment. In conclusion, adenovirus infections are an important cause of morbidity and mortality in adult BMT recipients, particularly allogeneic transplant recipients with GVHD who are receiving immunosuppressive therapy. The need for an effective, nontoxic antiviral therapy is apparent.
AuthorsA M La Rosa, R E Champlin, N Mirza, J Gajewski, S Giralt, K V Rolston, I Raad, K Jacobson, D Kontoyiannis, L Elting, E Whimbey
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 32 Issue 6 Pg. 871-6 (Mar 15 2001) ISSN: 1058-4838 [Print] United States
PMID11247710 (Publication Type: Journal Article)
Topics
  • Adenoviridae Infections (drug therapy, epidemiology, etiology)
  • Adult
  • Bone Marrow Transplantation (adverse effects, mortality)
  • Female
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation (adverse effects, mortality)
  • Humans
  • Immunosuppression Therapy
  • Male
  • Middle Aged
  • Risk Factors
  • Survival Rate
  • Transplantation, Autologous
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: